ADforus Co., Ltd. Logo

ADforus Co., Ltd.

Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.

397810 | KO

Overview

Corporate Details

ISIN(s):
KR7397810003
LEI:
Country:
South Korea
Address:
서울특별시 강남구 강남대로 560 7층(삼익전자빌딩), 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ADforus Co., Ltd. is an ad-tech company specializing in mobile performance marketing. Established in 2014, the company develops and operates its own proprietary advertising platforms, leveraging artificial intelligence (AI) and a differentiated big data platform to deliver optimized digital advertising solutions. ADforus provides comprehensive online and mobile marketing services for advertisers seeking effective campaigns and offers efficient monetization solutions for global publishers. The firm focuses on enhancing advertising effectiveness and return on investment for its clients through innovative technology and strategic marketing expertise.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 67.3 KB
2025-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 151.7 KB
2025-08-29 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-08-29 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-29 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-08-29 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-26 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 73.6 KB
2025-08-06 00:00
Share Issue/Capital Change
증권발행실적보고서(합병등)
Korean 78.3 KB
2025-06-17 00:00
Prospectus
투자설명서
Korean 3.6 MB
2025-06-04 00:00
Registration Form
[기재정정]증권신고서(합병)
Korean 5.2 MB
2025-05-26 00:00
Registration Form
[기재정정]증권신고서(합병)
Korean 5.4 MB
2025-05-15 00:00
Registration Form
증권신고서(합병)
Korean 3.4 MB
2025-04-08 00:00
Annual / Quarterly Financial Statement
감사보고서 (2024.12)
Korean 412.0 KB
2025-04-08 00:00
Audit Report / Information
연결감사보고서 (2024.12)
Korean 451.0 KB

Automate Your Workflow. Get a real-time feed of all ADforus Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ADforus Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ADforus Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nuvectis Pharma, Inc. Logo
Clinical-stage biopharma developing precision medicines for serious oncological conditions.
United States of America
NVCT
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway
NYKD
Ocugen, Inc. Logo
Develops gene/cell therapies and vaccines, specializing in blindness and public health.
United States of America
OCGN
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland
OCS
OKYO Pharma Ltd Logo
Biopharma developing novel drugs for inflammatory eye diseases and neuropathic corneal pain.
United States of America
OKYO
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea
244460
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
United States of America
OABIW
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea
382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea
476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan
4564

Talk to a Data Expert

Have a question? We'll get back to you promptly.